Stifel Maintains Teladoc Health at Hold, Raises Target to $6.50
Stifel kept its Hold rating and raised its price target from $5.50 to $6.50. The new target implies 5.5% downside from the Oct. 28 close of $6.88.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Teladoc Health 12-Month Price Target Raised to $7.61
The 12-month price target implies 11% upside.
TDOC target raised
Jefferies increases price target for Teladoc Health Inc. Analysts upgrade outlook for the company.